Maureen T. Kavanah, MD is Associate Professor Emeritus of surgery at BU School of Medicine (BUSM) and a surgical oncologist at Boston Medical Center (BMC), received the prestigious 2012 National Surgical Adjuvant Breast and Bowel Project (NSABP) Distinguished Investigator Lifetime Achievement Award for her extraordinary contributions and meritorious service to the NSABP in support of clinical research in breast and colorectal cancers.
During her nearly three decades of service on the Boston University Medical Campus, Dr. Kavanah has exemplified the spirit of the award through her dedication to the promotion, publication, and presentation of clinical research. “This award reflects not only Dr. Kavanah’s commitment to excellence in research and patient care, but to advancing treatment for breast cancer nationally and internationally,” says Gerard Doherty, MD, the James Utley Professor and Chair of Surgery at BUSM and chief of surgery at BMC.
Dr. Kavanah became a research investigator with the NSABP in 1981, and has since held several leadership positions within the organization. As the principal investigator of NSABP Clinical Research at BMC, she has led numerous NSABP-sponsored clinical studies in breast and bowel cancers. She has served on NSABP’s Board of Directors since 1988 and also serves as the protocol chair for the Breast Cancer Prevention Trial (P-1) and chair of the Ethics Committee.
In addition to her renowned scientific achievements, Dr. Kavanah has dedicated her time to the scientific community by serving as a faculty supervisor for many young investigators. In 1990, she established BMC as a full-member institution of the Southwest Oncology Group (SWOG) and served as its principal investigator until 1994. Dr. Kavanah belongs to numerous professional organizations and has been a member of the Board of Governors of the American College of Surgeons, president of the Massachusetts chapter of the American College of Surgeons, president of the New England Cancer Society, and chair of the National Cancer Institute Central Institutional Review Board. She lectures extensively and has been chosen as a “Top Doctor” by Boston Magazine annually since 2008.
Dr. Kavanah received the 2012 award during a ceremony held in Scottsdale, Arizona, on April 29 at the NSABP clinical trials annual meeting. The NSABP Foundation, Inc., has a 50-year history of designing and conducting clinical trials that have changed the standard of treatment for breast and colorectal cancers
- Tufts University School of Medicine, MD
- Emmanuel College, AB
- Published on 12/4/2019
Kim NE, Conway-Pearson L, Kavanah M, Mendez J, Sachs TF, Drake FT, Ko NY, McAneny D, Cassidy MR. Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation. J Am Coll Surg. 2020 06; 230(6):947-955. PMID: 31809861.
- Published on 12/1/2019
Feeney T, Cassidy M, Tripodis Y, McAneny D, Kavanah M, Sachs T, Tseng JF, Drake FT. Correction to: Association of Primary Language with Outcomes After Operations Typically Performed to Treat Cancer: Analysis of a Statewide Database. Ann Surg Oncol. 2019 12; 26(Suppl 3):887-888. PMID: 31313031.
- Published on 6/11/2019
Feeney T, Cassidy M, Tripodis Y, McAneny D, Kavanah M, Sachs T, Tseng JF, Drake FT. Association of Primary Language with Outcomes After Operations Typically Performed to Treat Cancer: Analysis of a Statewide Database. Ann Surg Oncol. 2019 Sep; 26(9):2684-2693. PMID: 31187361.
- Published on 11/20/2011
Battaglia TA, Howard MB, Kavanah M, Prout MN, Chapman C, David MM, McKinney R, Kronman A, Dumont T, Freund KM. The addition of internists to a breast health program. Breast J. 2012 Jan-Feb; 18(1):58-64. PMID: 22098389.
- Published on 3/2/2010
Graham K, de las Morenas A, Tripathi A, King C, Kavanah M, Mendez J, Stone M, Slama J, Miller M, Antoine G, Willers H, Sebastiani P, Rosenberg CL. Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. Br J Cancer. 2010 Apr 13; 102(8):1284-93. PMID: 20197764.
- Published on 8/21/2009
Emery LA, Tripathi A, King C, Kavanah M, Mendez J, Stone MD, de las Morenas A, Sebastiani P, Rosenberg CL. Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression. Am J Pathol. 2009 Sep; 175(3):1292-302. PMID: 19700746.
- Published on 4/1/2008
Tripathi A, King C, de la Morenas A, Perry VK, Burke B, Antoine GA, Hirsch EF, Kavanah M, Mendez J, Stone M, Gerry NP, Lenburg ME, Rosenberg CL. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int J Cancer. 2008 Apr 1; 122(7):1557-66. PMID: 18058819.
- Published on 10/1/2006
Méndez JE, Lamorte WW, de Las Morenas A, Cerda S, Pistey R, King T, Kavanah M, Hirsch E, Stone MD. Influence of breast cancer margin assessment method on the rates of positive margins and residual carcinoma. Am J Surg. 2006 Oct; 192(4):538-40. PMID: 16978970.
- Published on 11/16/2005
Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 2005 Nov 16; 97(22):1652-62. PMID: 16288118.
- Published on 11/1/2002
Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg. 2002 Nov; 137(11):1253-7. PMID: 12413312.
View 15 more publications: View full profile at BUMC